Blood donor screening tests
Active Purchase Order Awarded Last action
- Contract number
- HT941024P0103
- Awardee
-
Bloodworks UEI ZN56PFWUDQK7
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $164,749
Award facts
- Opportunity
-
- Blood Donor Screening Tests approved by FDA for Blood Donations - US Naval Hospital Okinawa, Japan Solicitation · HT941024Q2024 · Posted Feb 20, 2024
- Contract value 10% obligated
-
- $1,069,538.01 Current, with exercised options
- $1,617,380.01 Potential, with all options
- Completion date 59% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Seattle, WA 98104, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $4,528 | |
| Supplemental Agreement for work within scope | -$183,027 | |
| Supplemental Agreement for work within scope | -$314,583 | |
| Supplemental Agreement for work within scope | -$130,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $265,191 | |
| Supplemental Agreement for work within scope | $205,601 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $207,800 | |
| Original award | $109,239 |
About this award
The Defense Health Agency awarded a firm fixed price purchase order to Bloodworks, doing business as Puget Sound Blood Center And Program, on February 27, 2024, with a ceiling value of $1,617,689.06 and no set-aside. The order covers blood donor screening tests and blood donor screening test supplies, with ultimate completion on September 30, 2028. The award record lists Seattle, Washington as place of performance, while the originating solicitation specifies the U.S. Naval Hospital in Okinawa, Japan. That solicitation, posted February 20, 2024 with quotes due February 26, 2024, sought enzyme immunoassay testing of blood donor samples under FDA-approved methods, estimated at approximately 5,000 samples annually across 14 blood screening tests. It was structured as a base period and four one-year options running February 2024 through February 2029. Award was made on a best value tradeoff, with past performance weighted above price. NAICS 325413 applies, with a 1,250-employee size standard.
Quick answers
Who was awarded contract HT941024P0103?
HT941024P0103 was awarded to Bloodworks by Defense Health Agency (Department of Defense) on February 27, 2024.
How much is contract HT941024P0103 worth?
The government has obligated $164,749 on HT941024P0103. Its current value, with exercised options, is $1,069,538. Its potential value, with all options, is $1,617,380.
Was contract HT941024P0103 competed?
The extent of competition for HT941024P0103 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award